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Summary
Piperacillin is a beta-lactam antibiotic of penicillin family. Some penicillins were reported 
as occupational diseases cause, but piperacillin anaphylaxis with occupational sensitization 
is rare. We describe the case of a female nurse with recurrent anaphylaxis in last few months 
without apparent cause, only in work environment. Latex allergy was excluded after negative 
latex glove provocation. Later during diagnostic workup, the patient reported a similar reac-
tion minutes after piperacillin preparation. She denied any previous antibiotic therapeutic 
exposure. Skin prick tests (SPT) to beta-lactams were positive to piperacillin, penicillin G and 
major and minor determinants. SPT to cefuroxime was negative but intradermic test was 
positive. The patient has indication for beta-lactams eviction and for adrenaline auto-injector 
kit. No further reactions occurred after patient’s transfer to another department with mini-
mum possible exposure. Allergic risk prevention is essential and must be rapidly implemented 
to avoid incapacitating occupational diseases development.
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Introduction
Anaphylaxis is a rapid-onset, multisystem hypersensitivity reac-
tion with potentially fatal outcome (1). Clinically, anaphylaxis 
most frequent manifestations are cutaneous; however, respira-
tory, cardiovascular, gastrointestinal, and other symptoms may 
also occur (1). Drug-induced anaphylaxis (DIA) hypersensitiv-
ity mechanism is mainly an IgE-mediated response, but others 
have been characterized (1). Penicillin was in the past DIA most 
frequent cause, but was recently surpassed by amoxicillin (1). 
Healthcare professionals (HCP) are exposed to a large number 
of substances that act as allergens and/or irritants (2). These al-
lergenic substances were known to cause contact dermatitis, but 
nowadays a wide spectrum of clinical manifestations like asth-
ma, rhinitis, conjunctivitis and anaphylaxis is also included (2).
Piperacillin is an extended-spectrum beta-lactam antibiotic of 
the ureidopenicillin family, commonly used in combination 
with tazobactam, a beta-lactamase inhibitor. Some penicillins 
have been reported to cause occupational diseases (3-7), but 
only one case of piperacillin anaphylaxis with occupational 
sensitization has been described, and the diagnosis was only 
supported by serum IgE antibody detection (8). The authors 
describe the first case report of piperacillin anaphylaxis with oc-
cupational sensitization and diagnosis confirmed by skin tests.
Case report
A 28 year-old female nurse, with previous rhinitis history, 
was referenced to our outpatient clinic due to, in the last few 
months, recurrent episodes of generalized pruritus and cuta-
Vol 50, n 2, 89-91, 2018
90 J. Gaspar-Marques, E. Finelli, P.C. Martins, S. Prates, P. Leiria-Pinto
vitro assays are available, although most are not adequately val-
idated (11). We used a validated and indicated in vivo method-
ology (14) and this may be a strength of our study compared 
to the previously published similar case (8). There is clinically 
significant cross-reactivity between penicillins, and much less or 
possibly no clinically significant cross-reactivity between specific 
penicillins, cephalosporins, and other non-penicillin beta-lac-
tams (15). Piperacillin shares the beta-lactam ring with ampi-
cillin, amoxicillin and cloxacillin (16) and so these antibiotics 
must be avoided in this patient. The sensitization found to ce-
furoxime may represent a co-sensitization also due to exposure, 
or might be associated to beta-lactams cross-reactivity. The clin-
ical relevance of cefuroxime sensitization should be evaluated 
by DPT. Carbapenems and monobactams are also safely used 
in individuals with confirmed penicillin allergy (15) and may 
constitute another alternative.
In this case, sensitization was probably due to occupational 
nontherapeutic exposure to antibiotics. It can occur by various 
routes, and contact with spilled drugs and powder or foam in-
halation are the most common (4). Cutaneous sensitization is 
often fast, in weeks or months (2), and was probably enhanced 
in this patient by a damaged skin barrier leading to local and 
systemic immune responses (17). Clearly identified risk factors 
for drug-induced anaphylaxis, like female sex or concurrent 
medications, do not include professional exposure (1), although 
some studies point out that HCP seem to have an increased 
risk of penicillin allergy (18,19). Lifelong avoidance of the drug 
and cross-reactive drugs is recommended when drug-induced 
anaphylaxis has occurred (13).
Piperacillin is provided as a powder, and should be dissolved 
prior to administration. This antibiotic preparation generates 
more aerosolization than other intravenous antibiotics (8). This 
patient had anaphylaxis without direct drug contact, suggesting 
that piperacillin inhalation may be another major route of sen-
sitization or symptoms trigger.
One possible limitation of this case report is the relative uncer-
tainty about sensitization route, although both patient and par-
ents denied recent and frequent therapeutic exposures, as well as 
in remote past. This question was several times reconfirmed and 
this is a strength compared to the previously published report 
where occupational sensitization was assumed only based in oc-
cupational exposure (8).
Technical prevention is based on risk elimination, possibly re-
placing products or substances responsible for allergic manifes-
tations to non-sensitizing agents (2). Allergic risk prevention 
is essential, and must be rapidly implemented to prevent inca-
pacitating occupational diseases. The authors describe the case 
report of a health care professional that developed beta-lactams 
allergy in the context of occupational exposure.
neous erythema, face swelling, chest urticarial papules, cough, 
dyspnea, wheezing and sometimes abdominal pain without ap-
parent cause. The patient worked in the internal medicine ward 
for 5 years, and episodes were only work-environment related, 
excluding similar home episodes. These clinical manifestations 
usually resolved minutes after hydrocortisone intravenous ad-
ministration. As other allergic diseases, the patient reported 
hand contact dermatitis with latex gloves. Patch testing previ-
ously performed in the dermatology department found a meth-
ylchloroisothiazolinone sensitization. The patient used only ni-
trile gloves, although latex gloves were used in the ward. In the 
first appointment the patient denied any association between 
the manifestations and food, drugs or latex exposure. She also 
denied previous surgeries, food or drug allergy and any previous 
antibiotic therapeutic exposure. Her parents also confirmed this 
last fact. Skin prick tests (SPT) identified sensitization to aeroal-
lergens. Due to patient’s occupation and work-environment in-
volvement, a detailed latex allergy investigation was performed, 
including a latex glove provocation procedure that was negative. 
Due to diagnosis absence, the patient was instructed to regis-
ter all possible triggers, and an adrenaline auto-injector kit was 
prescribed. Two months later, a similar reaction occurred min-
utes after piperacillin-tazobactam preparation in work context. 
The patient reconfirmed that she was never treated with any 
antibiotic and had no accidental administration of this or oth-
er drug. Beta-lactams SPT, including piperacillin-tazobactam, 
were positive to piperacillin-tazobactam (2.5 mg/mL), penicil-
lin G and major and minor determinants. SPT to cefuroxime 
was negative, but intradermic test was positive (2.5 mg/mL). 
Available beta-lactams specific IgE determinations were all neg-
ative: amoxicillin, ampicillin, penicillin G and penicillin V. The 
patient has now indication for beta-lactams eviction. After the 
diagnosis the patient was transferred to the nuclear medicine 
department to minimize beta-lactams exposure risk and since 
then no further reactions occurred.
Discussion
Patient’s clinical manifestations can be classified as moderate 
anaphylaxis (9), and as occupational anaphylaxis as the triggers 
and conditions are only work-environment related (10). This 
case illustrates how a detailed history is essential in drug allergy 
workup (11), although drug provocation test (DPT) is the di-
agnostic “gold standard” due to its finest sensitivity (12). In this 
patient DPT was not performed, but occupational anaphylaxis 
diagnosis can be established based in the temporal relationship 
between piperacillin handling and manifestations, the pipera-
cillin positive SPT (13) and the absence of exposure other than 
preparation handling. For immediate IgE-mediated hypersen-
sitivity reactions, the presence of drug-specific IgE is usually 
taken as sufficient diagnostic evidence (11,13). Specific IgE in 
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